Resistance of some barley cultivars to leaf rust,Puccinia hordei; polygenic,partial resistance hidden by monogenic hypersensitivity

Three cultivars, all carrying the Pa7 gene for low infection type were crossed with ‘L94’, a cultivar assumed to carry no genes for partial resistance. The latent period (LP), the most important component determining partial resistance, was measured on 111 F₂ plants not carrying the Pa7 gene and on four cultivars representing the known range in LP. Of 20 F₃ lines the LP was evaluated, too. The F₂ showed a continuous segregation for LP from nearly as short as ‘L94’ to as long as ‘Vada’. This was substantiated by the F₃ data. The cultivars possessing the Pa7 gene are assumed to carry a series of minor genes, covered by Pa7, which govern a LP at least as long as that of ‘Vada’, a cultivar with a very high level of partial resistance and a long LP.     

Accumulating polygenes for partial resistance in barley to barley leaf rust,Puccinia hordei. I. Selection for increased latent periods

Summary The barley cultivar Cebaba Capa was crossed to the cultivar L94, which is assumed to carry no genes for increased latent periods, and Vada, which is assumed to carry five to six minor genes for a longer latent period (LP). In the F2 selection was carried out for short and long LP's in the young flag leaves to Puccinia hordei in both crosses. In the F3, F4 and F5 the selection for short as well as for long LP continued by selecting the extreme plants in the extreme lines, a typical pedigree selection approach.The LP's are given relative to those of L94, set at 100 and of Vada, set at 185. From the cross with L94 homogeneous lines were obtained with relative LP's of 100 and of 220. From the cross with Vada the extreme lines had LP's of 135 and around or even beyond 300.Cebaba Capa is thought to carry four to six minor genes with an average gene effect slightly larger than those of the five to six minor genes in Vada. From the four to six minor genes one or two may be identical to or closely linked with minor genes of Vada, the others appeared to be different. In the lines with LP's of close to 300 or even more the number of minor genes accumulated is thought to be in the order of eight or nine. These gene number estimates are based on independent assortment. If linkage occurs the number of genes involved may be larger.Because of the high correlation between LP in the young flag leaf and the partial resistance in the field the selected lines are assumed to have a partial resistance to barley leaf rust far beyond that of Vada, which represents almost the highest level of partial resistance in European cultivars.     

Corpus Luteum Development and Function after Supplementation of Long‐Acting Progesterone During the Early Luteal Phase in Beef Cattle

Strategic supplementation of P4 may be used to increase conception rates in cattle, but timing of supplementation in relation to ovulation, mass of supplementary P4 and formulation of the P4‐containing supplement has not been determined for beef cattle. Effects of supplementation of long‐acting progesterone (P4) on Days 2 or 3 post‐ovulation on development, function and regression of corpus luteum (CL) were studied in beef cattle. Cows were synchronized with an oestradiol/P4‐based protocol and treated with 150 or 300 mg of long‐acting P4 on Day 2 or 3 post‐ovulation (6–7 cows/group). Colour‐doppler ultrasound scanning and blood sample collection were performed from Day 2–21.5. Plasma P4 concentrations were greater (p < 0.05) from Day 2.5–5.5 in the Day 2‐treated groups and from Day 3.5–5.5 in the Day 3‐treated cows than in the control group. CL area and blood flow during Day 2–8.5 did not differ (p > 0.05) among groups, suggesting no effect of P4 treatment on luteal development. The frequency of cows that began luteolysis before Day 15 was greater (p < 0.04) in cows treated with 300 mg than in the controls, but there were no differences between non‐treated and 150 mg‐treated cows. The interval from pre‐treatment ovulation to functional and structural luteolysis was shorter (p < 0.01) in the combined P4‐treated groups than in the control cows. In conclusion, was showed for the first time that long‐acting P4 supplementation on Day 2 or 3 post‐ovulation increases P4 concentrations for ≥3 day, has no effect on luteal development, but anticipates the beginning of luteolysis in beef cattle.     

Familial occurrence of a congenital defect of the keratinisation of the skin in German Angus calves

Congenital dysfunction of the keratinisation of the epithelium was diagnosed in two female German Angus calves born on the same farm. The relationship coefficient between the two affected Angus calves was 34.38%. The clinical findings were similar to ichthyosis congenita as the alterations of the skin were present at birth and the levels of zinc in the blood were not decreased. However, parakeratosis could not be completely excluded as skin alterations were partly parakeratotic. On account of the close relationship between the two affected calves a genetic cause is likely for the present cases.     

Effects of pre‐operative administration of medetomidine on plasma insulin and glucose concentrations in healthy dogs and dogs with insulinoma

ObjectiveTo investigate the effect of medetomidine on plasma glucose and insulin concentrations in dogs with insulinoma and in healthy dogs undergoing anesthesia and surgery.AnimalsTwenty–five dogs with insulinoma and 26 healthy dogs.MethodsIn dogs with insulinoma, medetomidine (5 μg kg^?1) was randomly included (n = 12) or omitted (n = 13) from the pre–anesthetic medication protocol, which typically contained an opioid and an anticholinergic. Healthy dogs received medetomidine (5 μg kg^?1; n = 13) or acepromazine (0.04 mg kg^?1; n = 13) plus an opioid (morphine 0.5 mg kg^?1) and an anticholinergic (atropine 0.04 mg kg^?1) as pre–anesthetic medications. Pre–anesthetic medications were given intramuscularly. Plasma glucose and insulin concentrations were measured before (sample 1) and 30 minutes after pre–anesthetic medication (sample 2), and at the end of surgery in dogs with insulinoma or at 2 hours of anesthesia in healthy dogs (sample 3). Glucose requirement to maintain intra–operative normoglycemia in dogs with insulinoma was quantified and compared. Data were analyzed with anova and Bonferroni post–test, t–tests or chi–square tests as appropriate with p < 0.05 considered significant. Data are shown as mean ± SD.ResultsMedetomidine significantly decreased plasma insulin concentrations and increased plasma glucose concentrations in healthy dogs and those with insulinoma. These variables did not change significantly in the dogs not receiving medetomidine. In the dogs with insulinoma, intra–operative glucose administration rate was significantly less in the animals that received medetomidine compared to those that did not.ConclusionsPre–anesthetic administration of medetomidine significantly suppressed insulin secretion and increased plasma glucose concentration in dogs with insulinoma and in healthy dogs undergoing anesthesia and surgery.Clinical relevanceThese findings support the judicious use of medetomidine at low doses as an adjunct to the anesthetic management of dogs with insulinoma.